Lmr Partners LLP Legend Biotech Corp Call Options Transaction History

Lmr Partners LLP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$39.5 - $57.22 $387,100 - $560,756	-9,800 Reduced 79.03%	2,600 $115,000
Q1 2024 May 15, 2024	SELL	$55.06 - $69.99 $583,636 - $741,894	-10,600 Reduced 46.09%	12,400 $695,000
Q4 2023 Feb 14, 2024	BUY	$57.25 - $69.74 $1.32 Million - $1.6 Million	23,000 New	23,000 $1.38 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.25B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.